Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study

Table 2 Receipt of preventive services by women in the Lupus Outcomes Study and the general population

Service (LOS eligible group)	LOS 2005		CHIS 2005^§		CHIS 2005 ^§, with chronic conditions
	N (%)	95% CI	N (%)	95% CI	N (%)	95% CI
Cervical cancer screening¹ (women ≥ 65 years with a uterus)*	302 (70)	66 to 74	9,283 (73)	72 to74	1,917(74)	71 to 76
Mammogram² (≥ 40 years)*	384 (70)	67 to 74	8,875 (68)	67 to 69	2,449 (69)	67 to 71
Colon Cancer³ (≥ 50 years)*	221(62)	57 to 67	5,355 (57)	55 to 58	1,688 (59)	56 to 61
Influenza vaccine⁴ (≥ 50 years or immunosuppressed)^†	338 (59)	55 to 63	4,010 (42)	40 to 43	2,016 (38)	36 to 40
Pneumococcal vaccine⁵ (≥ 65 years or immunosuppressed)^†	272 (60)	56 to 65	3,074 (70)	68 to 72	1,756 (57)	54 to 60

§All data are from CHIS 2005, except for pneumococcal vaccine, for which the most recent CHIS data are from 2003. Chronic conditions examined in CHIS include self-reported diabetes mellitus, asthma or heart disease.
1. Compared to CHIS respondents 18 to 65 years with a uterus and no history of cervical cancer with health insurance.
2. Compared to CHIS ≥ 40 years, with no history of breast cancer with health insurance.
3. Compared to CHIS ≥ 50 years, with no history of colon cancer with health insurance.
4. Compared to the CHIS respondents ≥ 50 years with health insurance. For the CHIS sample with chronic conditions, all ages were considered eligible for the vaccine.
5. Compared to the CHIS general population age ≥ 65 with health insurance. For the CHIS sample with chronic conditions, immunization information was available for respondents ≥ 50 years.
*United States Preventive Services Task Force guidelines.
†Centers for Disease Control and Prevention guidelines.
Abbreviations: LOS, Lupus Outcomes Study; CHIS, California Health Interview Survey.

ISSN: 1478-6362